Search results
Showing 196 to 210 of 672 results for diabetes
Evidence-based recommendations on rivaroxaban (Xarelto) for preventing atherothrombotic events in adults with coronary or peripheral artery disease.
effective and cost effective among populations at higher risk of type 2 diabetes? This should consider the awareness, knowledge,...
Read biographies for all members of NICE's indicator advisory committee.
Read biographies for all members of NICE's indicator advisory committee.
This guideline covers diagnosing and managing hypertension (high blood pressure), including pre-eclampsia, during pregnancy, labour and birth. It also includes advice for women with hypertension who wish to conceive and women who have had a pregnancy complicated by hypertension. It aims to improve care during pregnancy, labour and birth for women and their babies.
treatment in people with type 1 diabetes? Any explanatory notes(if applicable) People with type 1 diabetes have increased...
NICE has developed a medtech innovation briefing (MIB) on FreeStyle Libre for glucose monitoring .
Human growth hormone (somatropin) for the treatment of growth failure in children (TA188)
Evidence-based recommendations on human growth hormone (somatropin; Genotropin, Humatrope, Norditropin, NutropinAq, Omnitrope, Saizen, Zomacton) for treating growth failure in children.
peripheral arterial disease in people with diabetes? Any explanatory notes(if applicable) People with diabetes are at...
Summary of the evidence on oral erythromycin for gastroparesis (delayed stomach emptying) in adults to inform local NHS planning and decision-making
Year Plan for healthcare. Podcasts 30 September 2025 Treating type 2 diabetes with SGLT-2 inhibitors In this episode, we discuss recent...
with diabetes to achieve blood glucose targets before pregnancy? Any explanatory notes(if applicable) Babies born to women with...
Canagliflozin for treating type 2 diabetes in people 10 to 17 years [TSID11888]
Awaiting development Reference number: GID-TA11377 Expected publication date: TBC
Tirzepatide for treating type 2 diabetes in people 10 to 17 years [ID6539]
Awaiting development Reference number: GID-TA11700 Expected publication date: TBC
Pelvic floor dysfunction: prevention and non-surgical management (NG210)
This guideline covers the prevention, assessment and non-surgical management of pelvic floor dysfunction in women aged 12 and over. It aims to raise awareness and help women to reduce their risk of pelvic floor dysfunction. For women who have pelvic floor dysfunction, the guideline recommends interventions based on their specific symptoms.